THE SCHEDULE 13D

Company

LIFECORE BIOMEDICAL, INC. \DE\

Filed

January 16, 2020

Accession Number

0000921895-20-000125

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →